Response on DCE-MRI predicts outcome of salvage radiotherapy for local recurrence after radical prostatectomy.

Published on Feb 1, 2021in Tumori1.707
· DOI :10.1177/0300891620908950
Giuseppe Sanguineti37
Estimated H-index: 37
Luca Bertini1
Estimated H-index: 1
+ 4 AuthorsValeria Landoni20
Estimated H-index: 20
OBJECTIVE: To assess the predictive role of response on dynamic contrast enhancement on magnetic resonance imaging (DCE-MRI) of visible local lesions in the setting of salvage radiotherapy (sRT) after radical prostatectomy. METHODS: All patients referred for sRT for biochemical failure after radical prostatectomy from February 2014 to September 2016 were considered eligible if they had been restaged with DCE-MRI and had been found to have a visible lesion in the prostatic bed, but no distant/nodal disease on choline positron emission tomography (PET)-computed tomography (CT). Eligible patients were contacted during follow-up and offered reimaging with serial DCE-MRI until lesion resolution. Complete response (CR) was defined as the disappearance of the target lesion on DCE-MRI; prostate-specific antigen (PSA) recurrence was defined as a 0.2 ng/mL PSA rise above the nadir. Median follow-up after sRT was 41.5 months (range, 12.1-61.2 months). RESULTS: Fifty-nine patients agreed to undergo repeated DCE-MRI for a total of 64 studied lesions. Overall, 57 lesions (89.1%) showed a CR after 1 (51 patients) or 2 (6 patients) scans, while 7 lesions did not show any change (no response [NR]). At 42 months, no evidence of biochemical disease (bNED) survival was 74.7+/-6.4% and 64.3+/-21.0% for patients with CR and NR lesions, respectively (hazard ratio [HR], 3.181; 95% confidence interval [CI], 0.157-64.364; p = 0.451). When only patients treated with sRT without androgen deprivation were selected (n = 41), bNED survival rates at 42 months were 72.1+/-8.0% and 0, respectively (HR, 52.830; 95% CI, 1.893-1474.110; p = 0.020). CONCLUSIONS: Patients whose lesions disappear during follow-up have a better outcome than those with unchanged lesions after sRT alone.
📖 Papers frequently viewed together
#1Alan Pollack (UM: University of Miami)H-Index: 83
#2Theodore KarrisonH-Index: 88
Last. H.M. Sandler (Cedars-Sinai Medical Center)H-Index: 14
view all 19 authors...
70 CitationsSource
#1Vidit Sharma (Mayo Clinic)H-Index: 15
#2Avinash Nehra (Mayo Clinic)H-Index: 9
Last. R. Jeffrey Karnes (Mayo Clinic)H-Index: 70
view all 9 authors...
Abstract Background The Stephenson nomogram is widely used to estimate the success of salvage radiotherapy (sXRT) for prostate cancer (PCa) recurrence after radical prostatectomy (RP). Objective To determine whether multiparametric pelvic magnetic resonance imaging (mpMRI) performed for biochemical recurrence after RP improves prognostication of sXRT relative to the Stephenson nomogram. Design, setting, and participants Men undergoing RP at our institution from 2003 to 2012 who had biochemical r...
12 CitationsSource
#1Kristina Sandgren (Umeå University)H-Index: 2
Last. Piet DirixH-Index: 27
view all 7 authors...
Abstract Context Local and regional recurrence after radical prostatectomy (RP) can be treated using salvage radiotherapy (SRT). If the recurrence can be delineated on diagnostic imaging, this could allow for increasingly individualized SRT. Objective This systematic review aimed at evaluating the evidence regarding the usefulness of positron emission tomography (PET) and magnetic resonance imaging (MRI) in identifying local and regional recurrences, with the aim to further individualize the SRT...
14 CitationsSource
#1Hashim U. Ahmed (UCL: University College London)H-Index: 62
#2Ahmed El-Shater Bosaily (UCL: University College London)H-Index: 6
Last. Mark Emberton (UCL: University College London)H-Index: 80
view all 14 authors...
Summary Background Men with high serum prostate specific antigen usually undergo transrectal ultrasound-guided prostate biopsy (TRUS-biopsy). TRUS-biopsy can cause side-effects including bleeding, pain, and infection. Multi-parametric magnetic resonance imaging (MP-MRI) used as a triage test might allow men to avoid unnecessary TRUS-biopsy and improve diagnostic accuracy. Methods We did this multicentre, paired-cohort, confirmatory study to test diagnostic accuracy of MP-MRI and TRUS-biopsy agai...
1,109 CitationsSource
#1Johannes SchwenckH-Index: 10
#2H. RemppH-Index: 1
Last. Christian la Fougère (DKFZ: German Cancer Research Center)H-Index: 41
view all 8 authors...
Purpose Prostate-specific membrane antigen (PSMA) is expressed ubiquitously on the membrane of most prostate tumors and its metastasis. While PET/CT using 11C-choline was considered as the gold standard in the staging of prostate cancer, PET with radiolabelled PSMA ligands was introduced into the clinic in recent years. Our aim was to compare the PSMA ligand 68Ga-PSMA-11 with 11C-choline in patients with primary and recurrent prostate cancer.
156 CitationsSource
#1Thomas M. Pisansky (Mayo Clinic)H-Index: 60
#2Shree Agrawal (Case Western Reserve University)H-Index: 7
Last. Rahul D. Tendulkar (Cleveland Clinic)H-Index: 21
view all 19 authors...
Purpose To determine whether a dose-response relationship exists for salvage radiation therapy (RT) of biochemical failure after prostatectomy for prostate cancer. Methods and Materials Individual data from 1108 patients who underwent salvage RT at 10 academic centers were pooled. The cohort was enriched for selection criteria more likely associated with tumor recurrence in the prostate bed (margin positive and pre-RT prostate-specific antigen [PSA] level of ≤2.0 ng/mL) and without the confoundi...
25 CitationsSource
#1Christopher R. King (UCLA: University of California, Los Angeles)H-Index: 37
Abstract Purpose/objectives To date neither the optimal radiotherapy dose nor the existence of a dose–response has been established for salvage RT (SRT). Materials/methods A systematic review from 1996 to 2015 and meta-analysis was performed to identify the pathologic, clinical and treatment factors associated with relapse-free survival (RFS) after SRT (uniformly defined as a PSA>0.2ng/mL or rising above post-SRT nadir). A sigmoidal dose–response curve was objectively fitted and a non-parametric...
42 CitationsSource
#1Rahul D. Tendulkar (Cleveland Clinic)H-Index: 21
#2Shree Agrawal (Case Western Reserve University)H-Index: 7
Last. Andrew J. Stephenson (Case Western Reserve University)H-Index: 57
view all 20 authors...
PurposeWe aimed to update a previously published, multi-institutional nomogram of outcomes for salvage radiotherapy (SRT) following radical prostatectomy (RP) for prostate cancer, including patients treated in the contemporary era.MethodsIndividual data from node-negative patients with a detectable post-RP prostate-specific antigen (PSA) treated with SRT with or without concurrent androgen-deprivation therapy (ADT) were obtained from 10 academic institutions. Freedom from biochemical failure (FF...
156 CitationsSource
#1Christina Bluemel (UCLA: University of California, Los Angeles)H-Index: 21
#2Markus Krebs (Ansbach)H-Index: 10
Last. Ken HerrmannH-Index: 67
view all 16 authors...
Investigating the value of 68Ga-PSMA-PET/CT in biochemically recurring prostate cancer patients with negative 18F-choline-PET/CT. One hundred thirty-nine consecutive patients with biochemical recurrence after curative (surgery and/or radiotherapy) therapy were offered participation in this sequential clinical imaging approach. Patients first underwent an 18F-choline-PET/CT. If negative, an additional 68Ga-PSMA-PET/CT was offered. One hundred twenty-five of 139 eligible patients were included in ...
120 CitationsSource
#1Kazuhiro Kitajima (Mayo Clinic)H-Index: 4
#2Robert P. Hartman (Mayo Clinic)H-Index: 25
Last. Akira Kawashima (Mayo Clinic)H-Index: 50
view all 6 authors...
OBJECTIVE. The purpose of this study was to assess the utility of DWI and dynamic contrast enhancement (DCE) in MRI at 3 T with an endorectal coil in identifying local prostate cancer recurrence after radical prostatectomy. MATERIALS AND METHODS. Eighty men underwent MRI for suspected local recurrence. The reference standards were histopathologic result, decrease in prostate-specific antigen level after salvage radiation therapy, and follow-up findings. Using a 5-point scoring system, two review...
36 CitationsSource
Cited By0